Literature DB >> 25212687

Mechanisms of tissue damage in arthritis.

Stephan Blüml1, Kurt Redlich, Josef S Smolen.   

Abstract

The destruction of articular structures in the course of inflammatory arthritides such as rheumatoid arthritis (RA) or seronegative spondyloarthropathies is the most serious direct consequence of these diseases. Indeed, joint damage constitutes the "organ damage" of RA and-just like in all other diseases with organ involvement-such damage will usually be irreversible, cause permanent loss of function and subsequent disability. Research has identified a number of mechanisms and mediators of damage to articular structures such as bone and cartilage, ranging from proinflammatory cytokines, signal transduction pathways and cells types, which will be discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25212687     DOI: 10.1007/s00281-014-0442-8

Source DB:  PubMed          Journal:  Semin Immunopathol        ISSN: 1863-2297            Impact factor:   9.623


  143 in total

Review 1.  Sphingosine-1-phosphate and lymphocyte egress from lymphoid organs.

Authors:  Jason G Cyster; Susan R Schwab
Journal:  Annu Rev Immunol       Date:  2011-12-05       Impact factor: 28.527

Review 2.  Role of NF-κB in the skeleton.

Authors:  Deborah Veis Novack
Journal:  Cell Res       Date:  2010-11-16       Impact factor: 25.617

3.  Oxidized phospholipids negatively regulate dendritic cell maturation induced by TLRs and CD40.

Authors:  Stefan Blüml; Stefanie Kirchberger; Valery N Bochkov; Gerhard Krönke; Karl Stuhlmeier; Otto Majdic; Gerhard J Zlabinger; Walter Knapp; Bernd R Binder; Johannes Stöckl; Norbert Leitinger
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

4.  The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.

Authors:  S Dihlmann; A Siermann; M von Knebel Doeberitz
Journal:  Oncogene       Date:  2001-02-01       Impact factor: 9.867

5.  Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells.

Authors:  Shinobu Saijo; Masahide Asano; Reiko Horai; Hiroaki Yamamoto; Yoichiro Iwakura
Journal:  Arthritis Rheum       Date:  2002-02

6.  Alternative p38 MAPKs are essential for collagen-induced arthritis.

Authors:  Gabriel Criado; Ana Risco; Dayanira Alsina-Beauchamp; María J Pérez-Lorenzo; Alejandra Escós; Ana Cuenda
Journal:  Arthritis Rheumatol       Date:  2014-05       Impact factor: 10.995

7.  Mobilization of natural killer cells inhibits development of collagen-induced arthritis.

Authors:  Jianmei W Leavenworth; Xiaoyang Wang; Carola Schellack Wenander; Pieter Spee; Harvey Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-22       Impact factor: 11.205

8.  The TSC-mTOR signaling pathway regulates the innate inflammatory response.

Authors:  Thomas Weichhart; Giuseppina Costantino; Marko Poglitsch; Margit Rosner; Maximilian Zeyda; Karl M Stuhlmeier; Thomas Kolbe; Thomas M Stulnig; Walter H Hörl; Markus Hengstschläger; Mathias Müller; Marcus D Säemann
Journal:  Immunity       Date:  2008-10-09       Impact factor: 31.745

9.  Mediation of the proinflammatory cytokine response in rheumatoid arthritis and spondylarthritis by interactions between fibroblast-like synoviocytes and natural killer cells.

Authors:  Antoni Chan; Andrew Filer; Greg Parsonage; Simon Kollnberger; Roger Gundle; Christopher D Buckley; Paul Bowness
Journal:  Arthritis Rheum       Date:  2008-03

10.  Cytokine mRNA profiling identifies B cells as a major source of RANKL in rheumatoid arthritis.

Authors:  Lorraine Yeo; Kai-Michael Toellner; Mike Salmon; Andrew Filer; Christopher D Buckley; Karim Raza; Dagmar Scheel-Toellner
Journal:  Ann Rheum Dis       Date:  2011-07-08       Impact factor: 19.103

View more
  15 in total

Review 1.  [Biologicals and small molecules for rheumatoid arthritis].

Authors:  Stephan Blüml
Journal:  Z Rheumatol       Date:  2020-04       Impact factor: 1.372

2.  MicroRNA-146a governs fibroblast activation and joint pathology in arthritis.

Authors:  Victoria Saferding; Antonia Puchner; Eliana Goncalves-Alves; Melanie Hofmann; Michael Bonelli; Julia S Brunner; Emine Sahin; Birgit Niederreiter; Silvia Hayer; Hans P Kiener; Elisa Einwallner; Ramzi Nehmar; Raphael Carapito; Philippe Georgel; Marije I Koenders; Mark Boldin; Gernot Schabbauer; Mariola Kurowska-Stolarska; Günter Steiner; Josef S Smolen; Kurt Redlich; Stephan Blüml
Journal:  J Autoimmun       Date:  2017-05-22       Impact factor: 7.094

3.  Inhibition of small HA fragment activity and stimulation of A2A adenosine receptor pathway limit apoptosis and reduce cartilage damage in experimental arthritis.

Authors:  Giuseppe M Campo; Antonio Micali; Angela Avenoso; Angela D'Ascola; Michele Scuruchi; Antonina Pisani; Antongiulio Bruschetta; Alberto Calatroni; Domenico Puzzolo; Salvatore Campo
Journal:  Histochem Cell Biol       Date:  2014-12-16       Impact factor: 4.304

4.  Eicosapentaenoic acid and docosapentaenoic acid monoglycerides are more potent than docosahexaenoic acid monoglyceride to resolve inflammation in a rheumatoid arthritis model.

Authors:  Caroline Morin; Pierre U Blier; Samuel Fortin
Journal:  Arthritis Res Ther       Date:  2015-05-29       Impact factor: 5.156

5.  Repository corticotropin injection as adjunctive therapy in patients with rheumatoid arthritis who have failed previous therapies with at least three different modes of action.

Authors:  Theresa Gillis; Megan Crane; Carly Hinkle; Nathan Wei
Journal:  Open Access Rheumatol       Date:  2017-07-19

6.  Differential inhibition of activity, activation and gene expression of MMP-9 in THP-1 cells by azithromycin and minocycline versus bortezomib: A comparative study.

Authors:  Jennifer Vandooren; Sofie Knoops; João L Aldinucci Buzzo; Lise Boon; Erik Martens; Ghislain Opdenakker; Elzbieta Kolaczkowska
Journal:  PLoS One       Date:  2017-04-03       Impact factor: 3.240

7.  Non-classical monocytes as mediators of tissue destruction in arthritis.

Authors:  Antonia Puchner; Victoria Saferding; Michael Bonelli; Yohei Mikami; Melanie Hofmann; Julia S Brunner; Michael Caldera; Eliana Goncalves-Alves; Nikolaus B Binder; Anita Fischer; Elisabeth Simader; Carl-Walter Steiner; Harald Leiss; Silvia Hayer; Birgit Niederreiter; Thomas Karonitsch; Marije I Koenders; Bruno K Podesser; John J O'Shea; Jörg Menche; Josef S Smolen; Kurt Redlich; Stephan Blüml
Journal:  Ann Rheum Dis       Date:  2018-06-29       Impact factor: 19.103

8.  Sinomenine Inhibits the Progression of Rheumatoid Arthritis by Regulating the Secretion of Inflammatory Cytokines and Monocyte/Macrophage Subsets.

Authors:  Weiwei Liu; Yajie Zhang; Weina Zhu; Chunhua Ma; Jie Ruan; Hongyan Long; Yue Wang
Journal:  Front Immunol       Date:  2018-09-26       Impact factor: 7.561

9.  IL-17 cytokines in bone healing of diabetic Charcot arthropathy patients: a prospective 2 year follow-up study.

Authors:  Agnetha Folestad; Martin Ålund; Susanne Asteberg; Jesper Fowelin; Ylva Aurell; Jan Göthlin; Jean Cassuto
Journal:  J Foot Ankle Res       Date:  2015-08-18       Impact factor: 2.303

Review 10.  Structural integrity versus radiographic progression in rheumatoid arthritis.

Authors:  Ennio Giulio Favalli; Andrea Becciolini; Martina Biggioggero
Journal:  RMD Open       Date:  2015-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.